vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Avery Dennison (AVY). Click either name above to swap in a different company.

Avery Dennison is the larger business by last-quarter revenue ($2.3B vs $1.2B, roughly 1.9× Alignment Healthcare, Inc.). Avery Dennison runs the higher net margin — 7.3% vs 0.9%, a 6.4% gap on every dollar of revenue. On growth, Avery Dennison posted the faster year-over-year revenue change (7.0% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 1.4%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Avery Dennison Corporation is an American multinational manufacturer and distributor of pressure-sensitive adhesive materials, apparel branding labels and tags, RFID inlays, and specialty medical products. The company is a member of the Fortune 500 and is headquartered in Mentor, Ohio.

ALHC vs AVY — Head-to-Head

Bigger by revenue
AVY
AVY
1.9× larger
AVY
$2.3B
$1.2B
ALHC
Growing faster (revenue YoY)
AVY
AVY
+81.7% gap
AVY
7.0%
-74.7%
ALHC
Higher net margin
AVY
AVY
6.4% more per $
AVY
7.3%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
1.4%
AVY

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ALHC
ALHC
AVY
AVY
Revenue
$1.2B
$2.3B
Net Profit
$11.4M
$168.1M
Gross Margin
28.9%
Operating Margin
10.7%
Net Margin
0.9%
7.3%
Revenue YoY
-74.7%
7.0%
Net Profit YoY
1.1%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
AVY
AVY
Q1 26
$1.2B
$2.3B
Q4 25
$1.0B
$2.3B
Q3 25
$993.7M
$2.2B
Q2 25
$1.0B
$2.2B
Q1 25
$926.9M
$2.1B
Q4 24
$701.2M
$2.2B
Q3 24
$692.4M
$2.2B
Q2 24
$681.3M
$2.2B
Net Profit
ALHC
ALHC
AVY
AVY
Q1 26
$11.4M
$168.1M
Q4 25
$-11.0M
$166.4M
Q3 25
$3.7M
$166.3M
Q2 25
$15.7M
$189.0M
Q1 25
$-9.1M
$166.3M
Q4 24
$-31.1M
$174.0M
Q3 24
$-26.4M
$181.7M
Q2 24
$-24.0M
$176.8M
Gross Margin
ALHC
ALHC
AVY
AVY
Q1 26
28.9%
Q4 25
28.7%
Q3 25
28.7%
Q2 25
28.8%
Q1 25
28.9%
Q4 24
27.9%
Q3 24
28.7%
Q2 24
29.6%
Operating Margin
ALHC
ALHC
AVY
AVY
Q1 26
10.7%
Q4 25
-1.0%
9.1%
Q3 25
0.8%
10.6%
Q2 25
2.2%
11.5%
Q1 25
-0.6%
10.6%
Q4 24
-3.2%
11.0%
Q3 24
-2.8%
11.0%
Q2 24
-2.7%
10.7%
Net Margin
ALHC
ALHC
AVY
AVY
Q1 26
0.9%
7.3%
Q4 25
-1.1%
7.3%
Q3 25
0.4%
7.5%
Q2 25
1.5%
8.5%
Q1 25
-1.0%
7.7%
Q4 24
-4.4%
8.0%
Q3 24
-3.8%
8.3%
Q2 24
-3.5%
7.9%
EPS (diluted)
ALHC
ALHC
AVY
AVY
Q1 26
Q4 25
$-0.04
$2.16
Q3 25
$0.02
$2.13
Q2 25
$0.07
$2.41
Q1 25
$-0.05
$2.09
Q4 24
$-0.15
$2.17
Q3 24
$-0.14
$2.25
Q2 24
$-0.13
$2.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
AVY
AVY
Cash + ST InvestmentsLiquidity on hand
$705.6M
$255.1M
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$206.9M
$2.3B
Total Assets
$1.3B
$9.0B
Debt / EquityLower = less leverage
1.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
AVY
AVY
Q1 26
$705.6M
$255.1M
Q4 25
$604.2M
$202.8M
Q3 25
$644.1M
$536.3M
Q2 25
$503.8M
$215.9M
Q1 25
$479.5M
$195.9M
Q4 24
$470.6M
$329.1M
Q3 24
$381.0M
$212.7M
Q2 24
$363.7M
$208.8M
Total Debt
ALHC
ALHC
AVY
AVY
Q1 26
$3.2B
Q4 25
$323.2M
$3.2B
Q3 25
$322.7M
$3.2B
Q2 25
$322.3M
$2.6B
Q1 25
$321.9M
$2.6B
Q4 24
$321.4M
$2.6B
Q3 24
$212.0M
$2.0B
Q2 24
$211.7M
$2.0B
Stockholders' Equity
ALHC
ALHC
AVY
AVY
Q1 26
$206.9M
$2.3B
Q4 25
$179.3M
$2.2B
Q3 25
$161.9M
$2.2B
Q2 25
$141.0M
$2.2B
Q1 25
$108.1M
$2.2B
Q4 24
$99.9M
$2.3B
Q3 24
$114.5M
$2.4B
Q2 24
$123.7M
$2.3B
Total Assets
ALHC
ALHC
AVY
AVY
Q1 26
$1.3B
$9.0B
Q4 25
$1.1B
$8.8B
Q3 25
$1.1B
$8.9B
Q2 25
$1.0B
$8.6B
Q1 25
$895.6M
$8.4B
Q4 24
$782.1M
$8.4B
Q3 24
$692.3M
$8.5B
Q2 24
$716.3M
$8.3B
Debt / Equity
ALHC
ALHC
AVY
AVY
Q1 26
1.38×
Q4 25
1.80×
1.43×
Q3 25
1.99×
1.45×
Q2 25
2.29×
1.19×
Q1 25
2.98×
1.19×
Q4 24
3.22×
1.11×
Q3 24
1.85×
0.85×
Q2 24
1.71×
0.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
AVY
AVY
Operating Cash FlowLast quarter
$128.7M
Free Cash FlowOCF − Capex
$104.4M
FCF MarginFCF / Revenue
4.5%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
11.27×
TTM Free Cash FlowTrailing 4 quarters
$869.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
AVY
AVY
Q1 26
$128.7M
Q4 25
$-50.4M
$376.8M
Q3 25
$144.6M
$312.1M
Q2 25
$29.1M
$208.8M
Q1 25
$16.6M
$-16.3M
Q4 24
$-8.7M
$351.2M
Q3 24
$26.2M
$270.1M
Q2 24
$23.5M
$197.7M
Free Cash Flow
ALHC
ALHC
AVY
AVY
Q1 26
$104.4M
Q4 25
$-55.4M
$309.7M
Q3 25
$139.1M
$276.2M
Q2 25
$21.1M
$178.8M
Q1 25
$8.4M
$-52.3M
Q4 24
$-18.0M
$281.7M
Q3 24
$16.9M
$227.1M
Q2 24
$11.8M
$150.2M
FCF Margin
ALHC
ALHC
AVY
AVY
Q1 26
4.5%
Q4 25
-5.5%
13.6%
Q3 25
14.0%
12.5%
Q2 25
2.1%
8.1%
Q1 25
0.9%
-2.4%
Q4 24
-2.6%
12.9%
Q3 24
2.4%
10.4%
Q2 24
1.7%
6.7%
Capex Intensity
ALHC
ALHC
AVY
AVY
Q1 26
Q4 25
0.5%
3.0%
Q3 25
0.6%
1.6%
Q2 25
0.8%
1.4%
Q1 25
0.9%
1.7%
Q4 24
1.3%
3.2%
Q3 24
1.3%
2.0%
Q2 24
1.7%
2.1%
Cash Conversion
ALHC
ALHC
AVY
AVY
Q1 26
11.27×
Q4 25
2.26×
Q3 25
38.77×
1.88×
Q2 25
1.86×
1.10×
Q1 25
-0.10×
Q4 24
2.02×
Q3 24
1.49×
Q2 24
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

AVY
AVY

Materials Group$1.6B72%
Solutions Group$649.2M28%

Related Comparisons